Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.